Peregrine Asset Advisers’s Array Biopharma Inc ARRY Stock Holding History

Peregrine Asset Advisers’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,094	Closed	-$435K	–	154
2020 Q4	$435K	Buy	+10,094	New	+$435K	0.2%	80

Peregrine Asset Advisers's ARRY Position: Q1 2021 in Review

Peregrine Asset Advisers sold out of Array Biopharma Inc (ARRY) in Q1 2021, closing a stake of 10,094 shares — an estimated $435K sold.

Peregrine Asset Advisers first reported a position in ARRY in Q4 2020 and held it in 1 quarter. The position peaked at $435K in Q4 2020. 0 funds tracked by Wall St. Rank hold ARRY as of Q1 2021.

Peregrine Asset Advisers reported no remaining Array Biopharma Inc position as of Q1 2021 after selling out during the quarter.
Peregrine Asset Advisers sold 10,094 Array Biopharma Inc shares in Q1 2021, an estimated $435K.
Peregrine Asset Advisers first reported a position in Array Biopharma Inc in Q4 2020 and held it in 1 quarter.
Peregrine Asset Advisers's Array Biopharma Inc position peaked at $435K in Q4 2020.
0 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2021.

Based on Peregrine Asset Advisers's 13F filing for Q1 2021, filed 13 May 2021.